Mitra Keluarga Karyasehat Tbk PT (MIKA)
Jakarta Exchange · Indonesia · prices in IDR · close of 19 Oct 2026
Key indicators
| Last close | IDR 1,375.00 |
|---|---|
| 52-week range | 1,361.78 – 2,636.01 |
| Return, 1 month / 3 months | −20.3% / −20.5% |
| Return, 1 year / 3 years | −45.4% / −49.3% |
| Trend | Below its 200-day average |
| RSI (14) | 19 |
| Volatility (1 year) | 36.4% |
| Worst drawdown (1 year) | -46.9% |
| Average daily value traded | 5,896.92M IDR |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mitra Keluarga Karyasehat is an Indonesian healthcare provider that runs a network of hospitals under the Mitra Keluarga name. Its hospitals offer general and specialist medical care, including inpatient wards, outpatient clinics, emergency services and diagnostic support, serving patients in cities across the country. The company is based in Indonesia and focuses on accessible private hospital care for local communities, with facilities staffed by doctors, nurses and other medical professionals.
On this site Mitra Keluarga Karyasehat Tbk PT appears as a stock on the Jakarta Exchange (Indonesia), code MIKA, with prices in Indonesian rupiah (IDR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mitra Keluarga Karyasehat Tbk PT (MIKA) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 1,375.00 on 19 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 433 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 45.4% and over the last three months it fell 20.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 41 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -27.6% | ||
| From 52-week high | -46.9% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.5% | ||
| 6-month return | -30.7% | ||
| 12-month return, skipping the last month | -31.5% | ||
| Risk (lower is better) | 69 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 36.4% | ||
| Worst drawdown (1 year) | -46.9% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 5,896.92M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | 57 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −20.7% |
|---|---|
| 1 month | −20.3% |
| 3 months | −20.5% |
| 6 months | −30.7% |
| 1 year | −45.4% |
| 3 years | −49.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1,773.80 / 1,899.92 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 64.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Jun 2026 | IDR 43.0000 |
| 17 Jun 2025 | IDR 43.0000 |
| 13 Jun 2024 | IDR 34.0000 |
| 5 Jun 2023 | IDR 37.0000 |
| 23 May 2022 | IDR 36.0000 |
| 21 Jun 2021 | IDR 36.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.